AwardTape · Defense awards · Research and development · Health R&D · HT942523C0036
HT942523C0036: $879K definitive contract to Beyond Barriers Therapeutics, Inc
Beyond Barriers Therapeutics, Inc holds a definitive contract from Defense Health Agency with $879K obligated since Oct 2023 and $1.9M obligated over its life, against a ceiling of $1.9M. Latest action Jan 13, 2026.
Intranasal treatment for mild traumatic brain injury (broad agency announcement number so190192)
| PIID | HT942523C0036 |
|---|---|
| Type | definitive contract |
| Company | Beyond Barriers Therapeutics, Inc |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY |
| Category | Research and development · Health R&D |
| PSC | AN12 HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| NAICS | 541715 RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| Obligated since Oct 2023 | $879K |
| Total obligated (lifetime) | $1.9M |
| Ceiling (base and all options) | $1.9M |
| Base date | Jul 25, 2023 |
| Latest action | Jan 13, 2026 |
| End date | Jan 24, 2027 |
| Actions since Oct 2023 | 5 |
| Pricing | Fixed price level of effort |
| Competition | Full and open competition |
| Place of performance | IL |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial